Vireo Growth (VREOF) FCF Margin (2020 - 2026)
Vireo Growth (VREOF) reported FCF Margin of 1.04% for Q1 2026, up 1940.0% on a YoY basis from 0.05% in Q1 2025, and down 87.69% sequentially from 8.41% in Q4 2025.
Vireo Growth (VREOF) FCF Margin (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of FCF Margin data on file, last reported at 1.04% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1940.0% year-over-year to 1.04%; the trailing twelve-month figure through Mar 2026 stood at 5.43% (up 1896.0% YoY), and the FY2025 full-year result was 9.16%, up 1291.0% from the prior year.
- FCF Margin slipped to 1.04% in Q1 2026, from 8.41% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 8.41% in Q4 2025 to a low of 57.13% in Q1 2022.
- A 5-year average of 17.54% and a median of 17.59% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 10796 bps in 2022 and slumped 3580 bps in 2024, its largest moves.
- Tracing VREOF's FCF Margin over 5 years: stood at 35.4% in 2022, then soared by 67 bps to 11.55% in 2023, then sank by 217 bps to 36.62% in 2024, then jumped by 123 bps to 8.41% in 2025, then slumped by 88 bps to 1.04% in 2026.
- Business Quant data shows VREOF's FCF Margin at 1.04% in Q1 2026, 8.41% in Q4 2025, and 22.31% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04% |
| Dec 31, 2025 | 8.41% |
| Sep 30, 2025 | -22.31% |
| Jun 30, 2025 | -17.59% |
| Mar 31, 2025 | -18.37% |
| Dec 31, 2024 | -36.62% |
| Sep 30, 2024 | -29.71% |
| Jun 30, 2024 | -12.74% |
| Mar 31, 2024 | -8.68% |
| Dec 31, 2023 | -11.55% |
| Sep 30, 2023 | 6.09% |
| Jun 30, 2023 | -3.20% |
| Mar 31, 2023 | -20.92% |
| Dec 31, 2022 | -35.40% |
| Sep 30, 2022 | -16.59% |
| Jun 30, 2022 | -22.91% |
| Mar 31, 2022 | -57.13% |
| Dec 31, 2021 | -82.04% |
| Sep 30, 2021 | -66.11% |
| Jun 30, 2021 | -130.86% |